|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Doorbar J: Molecular biology of human
papillomavirus infection and cervical cancer. Clin Sci.
110:525–541. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiménez-Wences H, Peralta-Zaragoza O and
Fernández-Tilapa G: Human papilloma virus, DNA methylation and
microRNA expression in cervical cancer (Review). Oncol Rep.
31:2467–2476. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Akagi K, Li J, Broutian TR, Padilla-Nash
H, Xiao W, Jiang B, Rocco JW, Teknos TN, Kumar B, Wangsa D, et al:
Genome-wide analysis of HPV integration in human cancers reveals
recurrent, focal genomic instability. Genome Res. 24:185–199. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schiffman M, Wentzensen N, Wacholder S,
Kinney W, Gage JC and Castle PE: Human papillomavirus testing in
the prevention of cervical cancer. J Natl Cancer Inst. 103:368–383.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liz J and Esteller M: lncRNAs and
microRNAs with a role in cancer development. Biochim Biophys Acta.
1859:169–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Morris KV and Mattick JS: The rise of
regulatory RNA. Nat Rev Genet. 15:423–437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reshmi G and Pillai MR: Beyond HPV:
Oncomirs as new players in cervical cancer. FEBS Lett.
582:4113–4116. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yao Q, Xu H, Zhang QQ, Zhou H and Qu LH:
MicroRNA-21 promotes cell proliferation and down-regulates the
expression of programmed cell death 4 (PDCD4) in HeLa cervical
carcinoma cells. Biochem Biophys Res Commun. 388:539–542. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hou T, Ou J, Zhao X, Huang X, Huang Y and
Zhang Y: MicroRNA-196a promotes cervical cancer proliferation
through the regulation of FOXO1 and p27Kip1. Br J
Cancer. 110:1260–1268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo M, Shen D, Zhou X, Chen X and Wang W:
MicroRNA-497 is a potential prognostic marker in human cervical
cancer and functions as a tumor suppressor by targeting the
insulin-like growth factor 1 receptor. Surgery. 153:836–847. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu X, Schwarz JK, Lewis JS Jr, Huettner
PC, Rader JS, Deasy JO, Grigsby PW and Wang X: A microRNA
expression signature for cervical cancer prognosis. Cancer Res.
70:1441–1448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Xue W, Lv J, Han P, Liu Y and Cui B:
Identification of potential long non-coding RNA biomarkers
associated with the progression of colon cancer. Oncotarget.
8:75834–75843. 2017.PubMed/NCBI
|
|
16
|
Zapf A, Brunner E and Konietschke F: A
wild bootstrap approach for the selection of biomarkers in early
diagnostic trials. BMC Med Res Methodol. 15:432015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Toloşi L and Lengauer T: Classification
with correlated features: Unreliability of feature ranking and
solutions. Bioinformatics. 27:1986–1994. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Q and Liu X: Screening of feature
genes in distinguishing different types of breast cancer using
support vector machine. Onco Targets Ther. 8:2311–2317.
2015.PubMed/NCBI
|
|
19
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human microRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Takebe N, Miele L, Harris PJ, Jeong W,
Bando H, Kahn M, Yang SX and Ivy SP: Targeting Notch, Hedgehog, and
Wnt pathways in cancer stem cells: Clinical update. Nat Rev Clin
Oncol. 12:445–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nwabo Kamdje AH, Takam Kamga P, Tagne Simo
R, Vecchio L, Seke Etet PF, Muller JM, Bassi G, Lukong E, Kumar
Goel R, Mbo Amvene J, et al: Developmental pathways associated with
cancer metastasis: Notch, Wnt, and Hedgehog. Cancer Biol Med.
14:109–120. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Culp TD, Budgeon LR, Marinkovich MP,
Meneguzzi G and Christensen ND: Keratinocyte-secreted laminin 5 can
function as a transient receptor for human papillomaviruses by
binding virions and transferring them to adjacent cells. J Virol.
80:8940–8950. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu J, Wang Y, Dong R, Huang X, Ding S and
Qiu H: Circulating microRNA-218 was reduced in cervical cancer and
correlated with tumor invasion. J Cancer Res Clin Oncol.
138:671–674. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kogo R, How C, Chaudary N, Bruce J, Shi W,
Hill RP, Zahedi P, Yip KW and Liu FF: The microRNA-218~Survivin
axis regulates migration, invasion, and lymph node metastasis in
cervical cancer. Oncotarget. 6:1090–1100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Liu J, Yuan C, Cui B, Zou X and Qiao
Y: High-risk human papillomavirus reduces the expression of
microRNA-218 in women with cervical intraepithelial neoplasia. J
Int Med Res. 38:1730–1736. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Scheffner M, Huibregtse JM, Vierstra RD
and Howley PM: The HPV-16 E6 and E6-AP complex functions as a
ubiquitin-protein ligase in the ubiquitination of p53. Cell.
75:495–505. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ye H, Yu X, Xia J, Tang X, Tang L and Chen
F: MiR-486-3p targeting ECM1 represses cell proliferation and
metastasis in cervical cancer. Biomed Pharmacother. 80:109–114.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun L, Jiang R, Li J, Wang B, Ma C, Lv Y
and Mu N: MicroRNA-425-5p is a potential prognostic biomarker for
cervical cancer. Ann Clin Biochem. 54:127–133. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ding H, Wu YL, Wang YX and Zhu FF:
Characterization of the microRNA expression profile of cervical
squamous cell carcinoma metastases. Asian Pac J Cancer Prev.
15:1675–1679. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Patterson EE, Holloway AK, Weng J, Fojo T
and Kebebew E: MicroRNA profiling of adrenocortical tumors reveals
miR-483 as a marker of malignancy. Cancer. 117:1630–1639. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang ZG, Ma XD, He ZH and Guo YX:
miR-483-5p promotes prostate cancer cell proliferation and invasion
by targeting RBM5. Int Braz J Urol. 43:1060–1067. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Song Q, Xu Y, Yang C, Chen Z, Jia C, Chen
J, Zhang Y, Lai P, Fan X, Zhou X, et al: miR-483-5p promotes
invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1
and ALCAM. Cancer Res. 74:3031–3042. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pan X, Wang R and Wang ZX: The potential
role of miR-451 in cancer diagnosis, prognosis, and therapy. Mol
Cancer Ther. 12:1153–1162. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu D, Liu C, Wang X, Ingvarsson S and
Chen H: MicroRNA-451 suppresses tumor cell growth by
down-regulating IL6R gene expression. Cancer Epidemiol. 38:85–92.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kleemann M, Bereuther J, Fischer S,
Marquart K, Hänle S, Unger K, Jendrossek V, Riedel CU, Handrick R
and Otte K: Investigation on tissue specific effects of
pro-apoptotic micro RNAs revealed miR-147b as a potential biomarker
in ovarian cancer prognosis. Oncotarget. 8:18773–18791. 2017.
View Article : Google Scholar : PubMed/NCBI
|
